Michael Adu-Frimpong
Overview
Explore the profile of Michael Adu-Frimpong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
377
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li J, Li T, Gong M, Wang X, Hua Q, Jiang X, et al.
J Drug Target
. 2025 Feb;
:1-45.
PMID: 39988918
Phloretin exhibits strong antioxidant and anti-aging properties by inhibiting mitochondrial oxidation of glutamate, succinic acid, and ascorbic acid. However, its clinical application is limited by poor aqueous solubility and low...
2.
Jiang X, Gong M, Jia Y, Adu-Frimpong M, Wang X, Hua Q, et al.
J Pharm Sci
. 2025 Feb;
:103703.
PMID: 39988296
Background: Chronic Kidney Disease (CKD) has become one of the major life-threatening conditions. Moringa seeds have been reported to exhibit renoprotective effects, with Niazimicin as its characteristic component. Objective: To...
3.
Liu H, Xu Q, Adu-Frimpong M, Chen Y, Li R, Xu F, et al.
J Chromatogr B Analyt Technol Biomed Life Sci
. 2024 Dec;
1251():124429.
PMID: 39721331
In order to enrich the selection of biological ligands, realize the miniaturization analysis, and broaden the application of monolith materials for active ingredients screening and separating, we sough to construct...
4.
Zou Z, Xue Y, Adu-Frimpong M, Wang C, Jin Z, Xu Y, et al.
AAPS PharmSciTech
. 2024 Nov;
25(8):261.
PMID: 39487315
This study aimed to construct a self-microemulsion drug delivery system (SMEDDS) for Formononetin (FMN) to improve its solubility and bioavailability while combining the nanocrystals (NCs) technology. The SMEDDS prescription composition...
5.
Shi F, Gong M, Adu-Frimpong M, Jiang X, Wang X, Hua Q, et al.
AAPS PharmSciTech
. 2024 Aug;
25(7):196.
PMID: 39174848
In this study, N, N '-bis {4- [(α-L- rhamnosyloxy) benzyl]} thiourea (PG-1), a phenolic glycoside compound was purified from Moringa seed. The PG-1 has attracted extensive attention due to its...
6.
Dang-I A, Atta I, Mbaadawu O, Ibrahim S, Abugri J, Adu-Frimpong M
Heliyon
. 2024 Aug;
10(14):e34934.
PMID: 39149011
The fruit of is respectively known among local folks in Ghana, Senegal, and Burkina Faso as , and . The plant has been used traditionally, ethnobotanically, and medicinally in most...
7.
Li C, Du M, Meng L, Adu-Frimpong M, Gong C, Zheng S, et al.
J Microencapsul
. 2024 Apr;
41(4):269-283.
PMID: 38618699
Aims: Myricetin (MYR) was incorporated into pH-sensitive liposomes in order to improve its bioavailability and anti-hyperuricemic activity. Methods: The MYR pH-sensitive liposomes (MYR liposomes) were prepared using thin film dispersion...
8.
Zhang H, Wei S, Hu Y, Zhang Y, Yao H, Qi G, et al.
Int J Nanomedicine
. 2024 Mar;
19:2807-2821.
PMID: 38525014
Background: Bufalin (BFL, an active anti-tumor compound derived from ) is limited in its application due to high toxicity and rapid metabolism of the cardiotonic steroid. Ester prodrug self-assembly nanoparticles...
9.
Zhang H, Zhang Y, Hu Y, Wei S, Adu-Frimpong M, Sun C, et al.
Drug Dev Ind Pharm
. 2024 Mar;
50(5):401-409.
PMID: 38466185
Objective: Magnolol (MG) and (L.) Merr. oil (BJO) possess synergetic anti-tumor effects, but have poor water solubility and stability, which results in low oral bioavailability. Significance: The MG loaded self-microemulsion...
10.
Jin X, Xia X, Li J, Adu-Frimpong M, Wang X, Wang Q, et al.
Drug Deliv Transl Res
. 2023 Nov;
14(5):1370-1388.
PMID: 37957475
At present, ulcerative colitis (UC) has become a global disease due to its high incidence. Hyperoside (HYP) is a naturally occurring flavonoid compound with many pharmacological effects. This study aimed...